Literature DB >> 9245900

Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues.

S Matsuda1, N Kanemitsu, A Nakamura, Y Mimura, N Ueda, Y Kurahashi, S Yamamoto.   

Abstract

Anandamide (arachidonylethanolamide) is an endogenous ligand for cannabinoid receptors, and exerts various cannabimimetic activities. Since cannabinoids and anandamide were pharmacologically active with the eye, we examined metabolism of anandamide in a variety of porcine ocular tissues. In the presence of ethanolamine, [14C]arachidonic acid was converted to [14C]anandamide by a homogenate of retina, choroid, iris, optic nerve and lacrimal gland with a specific enzyme activity of 1.9-4.2 nmol min-1 mg-1 protein at 37 degrees C. On the other hand, [14C]anandamide was hydrolysed to [14C]arachidonic acid by a homogenate of each tissue with a specific enzyme activity of 1.2-3.5 nmol min-1 mg-1 protein. Thus, both activities of anandamide synthase and hydrolase were found in these ocular tissues. As for the subcellular distribution, the two enzyme activities were mostly recovered in particulate fractions rather than the cytosol. With the retina microsome palmitic acid was converted to its ethanolamide at a lower rate than arachidonic acid, and palmitoylethanolamide was less active than anandamide as a substrate for the hydrolase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9245900     DOI: 10.1006/exer.1996.0265

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  12 in total

1.  Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system.

Authors:  A Straiker; N Stella; D Piomelli; K Mackie; H J Karten; G Maguire
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  Effects of the combination of bimatoprost and latanoprost on intraocular pressure in primary open angle glaucoma: a randomised clinical trial.

Authors:  L M Doi; L A S Melo; J A Prata
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

3.  Architecture of cannabinoid signaling in mouse retina.

Authors:  Sherry Shu-Jung Hu; Andy Arnold; Jacqueline M Hutchens; Josh Radicke; Benjamin F Cravatt; Jim Wager-Miller; Ken Mackie; Alex Straiker
Journal:  J Comp Neurol       Date:  2010-09-15       Impact factor: 3.215

4.  Endogenous Bioactive Lipids and the Regulation of Conventional Outflow Facility.

Authors:  Zhou Wan; David F Woodward; W Daniel Stamer
Journal:  Expert Rev Ophthalmol       Date:  2008

5.  A GPR18-based signalling system regulates IOP in murine eye.

Authors:  Meggie D Caldwell; Sherry Shu-Jung Hu; Suresh Viswanathan; Heather Bradshaw; Melanie E M Kelly; Alex Straiker
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

Review 6.  Endocannabinoids in the retina: from marijuana to neuroprotection.

Authors:  Stephen Yazulla
Journal:  Prog Retin Eye Res       Date:  2008-08-03       Impact factor: 21.198

7.  Cannabinoid signaling promotes the de-differentiation and proliferation of Müller glia-derived progenitor cells.

Authors:  Warren A Campbell; Sydney Blum; Alana Reske; Thanh Hoang; Seth Blackshaw; Andy J Fischer
Journal:  Glia       Date:  2021-07-07       Impact factor: 8.073

Review 8.  Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease.

Authors:  Despina Kokona; Panagiota-Christina Georgiou; Mihalis Kounenidakis; Foteini Kiagiadaki; Kyriaki Thermos
Journal:  Neural Plast       Date:  2016-01-06       Impact factor: 3.599

Review 9.  The Endocannabinoid System in the Retina: From Physiology to Practical and Therapeutic Applications.

Authors:  Thomas Schwitzer; Raymund Schwan; Karine Angioi-Duprez; Anne Giersch; Vincent Laprevote
Journal:  Neural Plast       Date:  2016-01-06       Impact factor: 3.599

Review 10.  Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy.

Authors:  Jan M Keppel Hesselink; Ciro Costagliola; Josiane Fakhry; David J Kopsky
Journal:  J Ophthalmol       Date:  2015-11-18       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.